Nephrology

Research and innovation from the nephrology experts at Vanderbilt Health

Latest in Nephrology

Circulating Vesicles Suspected in Cardiorenal Syndrome

Study finds circulating extracellular vesicles during acute heart failure can drive kidney injury.

Signaling Protein in Kidney Cancer Offers Potential Target

Loss of the von Hippel Lindau gene uniquely affects kidney cancer by upregulating a tumor-friendly chemokine.
Doctor holding patient's hand in critical care unit

Which Antibiotics to Choose for Hospital Infection?

Cefepime raised neurotoxicity risk; piperacillin-tazobactam did not raise risk to kidneys as previously thought.

Medical expertise infused with integrated technology allows Vanderbilt Health specialists to build partnerships and elevate care in complex and specialized cases. Browse our referral directory or log into our online portal for referring providers.

Make a Referral
Surgery team performing heart transplant

Transplant Excellence Result of Skill, Innovation and Teamwork

Vanderbilt surpasses its previous annual record for solid organ transplants, establishing it as the fifth-largest transplant center in the nation.
Gloved hands handling lab equipment

Inflammation Factors in Obesity and Kidney Injury

Studies connect receptor pathways to macrophages and inflammation in both obesity and kidney fibrosis.
Doctor and patient in consult

Exceptional Growth for Amyloidosis Care

Vanderbilt soars with emerging therapeutics and is the first dedicated amyloidosis treatment center in Tennessee.
Lonely looking black patient in hospital room

APOL1 Tied to Higher COVID-19 Mortality

Nationwide analysis finds variants may confer more than elevated risk of kidney disease.
Illustration of floating bacteria

How Bacteria Battles Acidity to Cause UTIs

A novel mechanism of acid resistance expands E. coli’s defenses and may guide researchers toward better treatment for a common infection.
illustration of mitosis in shades of red/pink

Mutated DNA Regulator Implicated in Cancer Cell Development

Studies on SETD2 identified correlations between mutated chromosomes in cancer cells and chemotherapy resistance.